ID

38781

Description

A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT01789788

Lien

https://clinicaltrials.gov/show/NCT01789788

Mots-clés

Versions (1)
  1. 03/11/2019 03/11/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

3 novembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus, Type 2 NCT01789788

Anglais

Eligibility Diabetes Mellitus, Type 2 NCT01789788

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, 18 to 65 years of age, inclusive
Description

Adult | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
type 2 diabetes mellitus according to who criteria diagnosed for at least 3 months prior to screening
Description

Non-Insulin-Dependent Diabetes Mellitus WHO classification | Non-Insulin-Dependent Diabetes Mellitus Disease length

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C4267671
UMLS CUI [2,1]
C0011860
UMLS CUI [2,2]
C0872146
on stable dose of metformin for at least 2 months prior to screening
Description

Metformin Dose Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
fasting plasma glucose during the screening period </= 240 mg/dl
Description

Plasma fasting glucose measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0583513
hemoglobin a1c (hba1c) levels at screening >/= 6.5% and </= 10.5%
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
evidence of insulin secretory capacity at screening
Description

Insulin Capacity secretory

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C1516240
UMLS CUI [1,3]
C1327616
body mass index (bmi) 27 to 42 kg/m2, inclusive
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
females of child-bearing potential and males with female partners of child-bearing potential must agree to use effective contraception as defined by protocol
Description

Childbearing Potential Contraceptive methods | Gender Partner Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0682323
UMLS CUI [2,3]
C3831118
UMLS CUI [2,4]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Description

Diabetes Mellitus, Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
acquired or secondary forms of diabetes such as those resulting from pancreatic surgery/injury, cystic fibrosis related diabetes
Description

Diabetes Mellitus Acquired | Secondary diabetes mellitus | Diabetes Mellitus Due to Pancreatic surgery | Diabetes Mellitus Due to Injury of pancreas | Cystic fibrosis related diabetes

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0439661
UMLS CUI [2]
C0271640
UMLS CUI [3,1]
C0011849
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C2033062
UMLS CUI [4,1]
C0011849
UMLS CUI [4,2]
C0678226
UMLS CUI [4,3]
C0273163
UMLS CUI [5]
C2242728
history of acute metabolic complications such as diabetic ketoacidosis or state of hyperosmolar hyperglycemia
Description

Complications Metabolic | Diabetic Ketoacidosis | Hyperglycemia hyperosmolar

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0311400
UMLS CUI [2]
C0011880
UMLS CUI [3]
C0745095
evidence or history of clinically significant diabetic complications such as clinically severe diabetic peripheral neuropathy, clinically significant nephropathy as judged by the investigator, or pre-proliferative/proliferative diabetic retinopathy as judged by the investigator
Description

Complications of Diabetes Mellitus | Diabetic peripheral neuropathy Severe | Kidney Disease | Preproliferative diabetic retinopathy | Proliferative diabetic retinopathy

Type de données

boolean

Alias
UMLS CUI [1]
C0342257
UMLS CUI [2,1]
C0740447
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0339473
UMLS CUI [5]
C0154830
history of severe symptomatic hypoglycemia (requiring assistances of a third party) within 6 months prior to screening
Description

Hypoglycemia Severe Symptomatic | Assistance Required

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0231220
UMLS CUI [2,1]
C1269765
UMLS CUI [2,2]
C1514873
history or presence of clinically significant concomitant disease or disorder
Description

Comorbidity Clinical Significance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2826293
hemoglobin level below the lower limit of reference range at screening
Description

Hemoglobin low

Type de données

boolean

Alias
UMLS CUI [1]
C0162119
pregnant or lactating women
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of anaphylaxis or severe systemic hypersensitivity or allergic reactions
Description

Anaphylaxis | Severe allergy Systemic | Allergic Reaction

Type de données

boolean

Alias
UMLS CUI [1]
C0002792
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0205373
UMLS CUI [3]
C1527304
Retour au début de la page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01789788

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, 18 to 65 years of age, inclusive
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Non-Insulin-Dependent Diabetes Mellitus WHO classification | Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes mellitus according to who criteria diagnosed for at least 3 months prior to screening
boolean
C0011860 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
Metformin Dose Stable
Item
on stable dose of metformin for at least 2 months prior to screening
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Plasma fasting glucose measurement
Item
fasting plasma glucose during the screening period </= 240 mg/dl
boolean
C0583513 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hemoglobin a1c (hba1c) levels at screening >/= 6.5% and </= 10.5%
boolean
C0474680 (UMLS CUI [1])
Insulin Capacity secretory
Item
evidence of insulin secretory capacity at screening
boolean
C0021641 (UMLS CUI [1,1])
C1516240 (UMLS CUI [1,2])
C1327616 (UMLS CUI [1,3])
Body mass index
Item
body mass index (bmi) 27 to 42 kg/m2, inclusive
boolean
C1305855 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Gender Partner Childbearing Potential Contraceptive methods
Item
females of child-bearing potential and males with female partners of child-bearing potential must agree to use effective contraception as defined by protocol
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C0682323 (UMLS CUI [2,2])
C3831118 (UMLS CUI [2,3])
C0700589 (UMLS CUI [2,4])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetes Mellitus Acquired | Secondary diabetes mellitus | Diabetes Mellitus Due to Pancreatic surgery | Diabetes Mellitus Due to Injury of pancreas | Cystic fibrosis related diabetes
Item
acquired or secondary forms of diabetes such as those resulting from pancreatic surgery/injury, cystic fibrosis related diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0439661 (UMLS CUI [1,2])
C0271640 (UMLS CUI [2])
C0011849 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C2033062 (UMLS CUI [3,3])
C0011849 (UMLS CUI [4,1])
C0678226 (UMLS CUI [4,2])
C0273163 (UMLS CUI [4,3])
C2242728 (UMLS CUI [5])
Complications Metabolic | Diabetic Ketoacidosis | Hyperglycemia hyperosmolar
Item
history of acute metabolic complications such as diabetic ketoacidosis or state of hyperosmolar hyperglycemia
boolean
C0009566 (UMLS CUI [1,1])
C0311400 (UMLS CUI [1,2])
C0011880 (UMLS CUI [2])
C0745095 (UMLS CUI [3])
Complications of Diabetes Mellitus | Diabetic peripheral neuropathy Severe | Kidney Disease | Preproliferative diabetic retinopathy | Proliferative diabetic retinopathy
Item
evidence or history of clinically significant diabetic complications such as clinically severe diabetic peripheral neuropathy, clinically significant nephropathy as judged by the investigator, or pre-proliferative/proliferative diabetic retinopathy as judged by the investigator
boolean
C0342257 (UMLS CUI [1])
C0740447 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0022658 (UMLS CUI [3])
C0339473 (UMLS CUI [4])
C0154830 (UMLS CUI [5])
Hypoglycemia Severe Symptomatic | Assistance Required
Item
history of severe symptomatic hypoglycemia (requiring assistances of a third party) within 6 months prior to screening
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
C1269765 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
Comorbidity Clinical Significance
Item
history or presence of clinically significant concomitant disease or disorder
boolean
C0009488 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Hemoglobin low
Item
hemoglobin level below the lower limit of reference range at screening
boolean
C0162119 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Anaphylaxis | Severe allergy Systemic | Allergic Reaction
Item
history of anaphylaxis or severe systemic hypersensitivity or allergic reactions
boolean
C0002792 (UMLS CUI [1])
C2945656 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C1527304 (UMLS CUI [3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial